Zhejiang Hisun Pharmaceutical Co., Ltd.

Zhejiang Teley Biotechnology Co., Ltd.

Xiaohe Zheng

Xiaoyu Liu

Hua Bai

Xuyang Zhao

Qifeng Zhu

Yi Bu Li

Bin Liu

Hui Zhang

Yongdong Wang

Wei Zhang

Zhiqing Yang

Yi Li

Peng Sun

Yuncai Zhang

Xiaojie Xu

Jidong Wang

Yong Zhang

Zhenliang Chen

Maojian Gu

Hairong Luo

Jinqing Zhong

Yongxiang Gong

Hegeng Wei

Yingqiu Wu

Tianmin Zhu

Lifei Liu

Yaping Wang

Lifeng Cai

Guojun Zheng

Zhongwei Wu

Hongyan Li

Chunhua Jin

Shoufeng Ming

Huan Qi

Ying Chen

Hailing Tang

Haiming Lin

Haibo Wang

Hongfu Kuang

Jian Hong

Zhengjiang Cai

Provided is a method for preparing a broccoli protein peptide. The method uses a broccoli protein as the raw material, and obtains a broccoli protein peptide powder through the steps of preprocessing, enzymatic hydrolysis, terminating enzymatic hydrolysis, separation, and drying and the like. Also provided is the use of the prepared broccoli protein peptide in resisting oxidation, reducing cholesterol and lowering blood lipids.

Method for preparing broccoli protein peptide mixture

The present invention relates to technical fields of organic chemistry and pharmaceutical chemistry, specifically to water-soluble rapamycin derivatives modified with glutathione. More specifically, the present invention discloses a compound of formula I and the preparation method thereof, wherein Rand Rare as defined in the description. The compound of formula I can be used in inducing immunosuppression and in the treatment of diseases such as transplant rejection and solid tumor, etc. 

Water-soluble rapamycin derivatives

The present invention discloses a 4-((substituted phenyl)difluoromethyl)phenoxycarboxylic acid derivative and preparation process and use thereof. More specifically, the present invention relates to a compound of the following formula I, which is defined in the specification. The compounds according to the present invention can be used as PPAR agonists, and demonstrates a strong effect on reducing the levels of total cholesterol (TC), triglyceride (TG), and low density lipoprotein cholesterol (LDL-C) in blood plasma, and thus the compound according to the present invention can be used in the preparation of a medicament for treating or preventing hyperlipoidemia or cardio-cerebrovascular diseases caused by hyperlipoidemia, such as diabetes, atherosclerosis, stroke, coronary heart disease, etc. The present invention also relates to a novel intermediate compound for the preparation of the compound of formula I and preparation method thereof.

4-((substituted phenyl) difluoromethyl) phenoxy carboxylic acid derivative, and preparation method and uses thereof

Provided in the present invention are novel benzodioxole derivatives and preparation methods thereof. These compounds represented by formula (I) or pharmaceutically acceptable salts thereof have acetylcholinesterase inhibitory activity, so can be used in the treatment or prevention of Alzheimer's disease. The definitions of R, Rand A of formula (I) can be seen in the description. 

Benzodioxole derivative and preparation method and use thereof

Phenyl propanoic acid compounds having activating effect on peroxisome proliferator-activated receptors (PPAR&#x3b1;,&#x3b4;,&#x3b3;) and a preparation method and uses thereof are provided in the present invention. The compounds can be used for treating or preventing diseases associated with peroxisome proliferator-activated receptors (PPAR&#x3b1;,&#x3b4;,&#x3b3;).

Compounds having activating effect on subtypes of peroxisome proliferator-activated receptors and its preparation method and uses

The present invention provides a novel compound of formula I, which has an agitation effect on the peroxisome proliferator-activated receptor subtype &#x3b4; (PPAR&#x3b4;), to a pharmaceutical composition comprising the compound, to a process for preparation of the compound and to use of the compound in the manufacture of a medicament for treating or preventing a disease which could be treated or prevented by activating PPAR&#x3b4; thereof, said disease is one or more from the group comprising metabolic syndrome, obesity, dyslipidemia, pathoglycemia, insulin resistance, senile dementia and tumors. The present invention also relates to a new intermediate used in the preparation of the novel compound and a process for preparation of the intermediate. 

Compound with agitation effect on peroxisome proliferator-activated receptor process for its preparation and use thereof

Preparation of azetidinone compounds and medical use thereof are provided by the present invention. More particularly, azetidionne compounds, shown as formula (I), wherein R, R, R, R, Rand Rare defined in description, and preparation methods thereof are provided by the present invention. The compounds of the present invention can reduce the levels of total cholesterol (TC) and low density lipoprotein cholesterol (LDL-C) in plasma, and can be used as medicaments for reducing cholesterol in blood. Therefore the compounds of the present invention can be used to treat or prevent diseases of atherosclerosis, cacergasia of blood vessel, cardiac failure, coronary artery disease, angiocardiopathy, myocardial, angina, hyperlipoidemia and hypercholesteremia and the like. Preparation method of compounds of formula (I) and intermediate compounds are also provided by the present invention. 

Azetidinone compounds and medical use thereof

Growing community of inventors

Taizhou, China

Xiaohe Zheng